Prognostic value of 17-Gene genomic prostate score in patients with clinically localized prostate cancer: a meta-analysis

Abstract Background The 17-gene Genomic Prostate Score (GPS) test has been clinically employed to predict adverse prognosis in prostate cancer. In this meta-analysis, we aimed to evaluate the prognostic value of the 17-gene GPS in patients with prostate cancer. Methods Potentially relevant studies w...

Full description

Bibliographic Details
Published in:	BMC Cancer
Main Authors:	Feilun Cui, Xuan Tang, Changfeng Man, Yu Fan
Format:	Article
Language:	English
Published:	BMC 2024-05-01
Subjects:	Genomic prostate score Prostate cancer Distant metastases Biochemical recurrence Prostate cancer–specific mortality Meta-analysis
Online Access:	https://doi.org/10.1186/s12885-024-12389-1

Similar Items

Pretreatment prostate-specific antigen density as a predictor of biochemical recurrence in patients with prostate cancer: a meta-analysis
by: Feilun Cui, et al.
Published: (2024-03-01)

Prostate cancer bone metastases confined to the distal left lower limb
by: Monique Vekeria, MBBS, BSc (Hons), FRCR, et al.
Published: (2021-09-01)

Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms
by: Michael Tzeng, et al.
Published: (2021-08-01)

Prostate‐specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low‐dose‐rate brachytherapy or external beam radiotherapy for localized prostate cancer
by: Shuichi Nishimura, et al.
Published: (2018-05-01)

Secondary Analysis of PSA and BCR-Free Survival in Asian Prostate Cancer Patients
by: Gao X, et al.
Published: (2025-06-01)

THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER
by: A. A. Gritskevich, et al.
Published: (2017-02-01)

Prognostic significance of a negative PSMA PET/CT in biochemical recurrence of prostate cancer
by: Sara Harsini, et al.
Published: (2024-08-01)

The Impact of Prostate Cancer Upgrading and Upstaging on Biochemical Recurrence and Cancer-Specific Survival
by: Arnas Bakavičius, et al.
Published: (2020-02-01)

Significance of the correlation between serum-prostate specific antigen and the percentage of prostate cancer volume in postoperative biochemical progression
by: Spasić Aleksandar, et al.
Published: (2017-01-01)

The value of post radiotherapy prostate specific antigen dynamics for prostate cancer risk stratification models
by: Jane Shortall, et al.
Published: (2025-04-01)

Outcomes of Salvage Prostate Cryotherapy: Real-life Experience of a Portuguese Oncologic Hospital
by: Luísa Jerónimo Alves, et al.
Published: (2021-09-01)

A novel prognostic risk score associated with resistance to docetaxel chemotherapy for predicting biochemical recurrence-free survival in patients with prostate cancer
by: Desheng Zhu, et al.
Published: (2025-08-01)

Weight gain or loss after diagnosis and survival outcomes in prostate cancer: a meta-analysis
by: Feilun Cui, et al.
Published: (2025-08-01)

The diagnostic value of a new formula combining age and prostate volume in prostate cancer
by: Xiaobo Yang, et al.
Published: (2022-02-01)

Use of a BMI-independent biomarker-based prostate cancer risk score to identify and triage individuals at risk of prostate disease
by: Joanne Watt, et al.
Published: (2025-07-01)

Association between preradiation therapy prostate-specific antigen levels and radiation therapy failure after prostatectomy: a propensity score matched analysis
by: Younsoo Chung, et al.
Published: (2024-06-01)

Perineural invasion, Gleason score and prostate specific antigen; is there any association?
by: Mohammad Yazdani, et al.
Published: (2019-10-01)

Clinical Issues for Prostate-Specific Antigen Screening: A Narrative Review
by: Marco Randazzo, et al.
Published: (2018-12-01)

Detection rate of fluorine-18 prostate-specific membrane antigen-1007 PET/CT for prostate cancer in primary staging and biochemical recurrence with different serum PSA levels: A systematic review and meta-analysis
by: Xue Liu, et al.
Published: (2022-07-01)

Detection Rates of PSMA-PET Radiopharmaceuticals in Recurrent Prostate Cancer: A Systematic Review
by: Soroush Rais-Bahrami, et al.
Published: (2025-05-01)

Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patients
by: Aravintho Natarajan, et al.
Published: (2019-07-01)

Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer
by: Chaoran Ma, et al.
Published: (2023-04-01)

PSA-Stratified Performance of [<sup>18</sup>F]DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer Patients under Androgen Deprivation Therapy
by: Sara Harsini, et al.
Published: (2022-09-01)

Short-term prognosis of low-risk prostate cancer patients is favorable despite the presence of pathological prognostic factors: a retrospective study
by: Remi Semba, et al.
Published: (2023-10-01)

Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01)

Prostate Specific Antigen Level and Gleason Score in Indonesian Prostate Cancer Patients
by: Muhammad Imam Al Kautsar Herawan, et al.
Published: (2024-09-01)

A retrospective study of prostate-specific antigen and international prostate symptoms scores from participants at a men’s health screening initiative in Trinidad
by: Raveed Khan, et al.
Published: (2024-07-01)

Usefulness of prostate specific antigen density in detecting prostate carcinoma: A hospital-based study in patients with prostate biopsies
by: Reshmi Shrestha, et al.
Published: (2022-03-01)

Factors associated with biochemical recurrence of prostate cancer post radical prostatectomy
by: Ezekiel E. Radebe, et al.
Published: (2024-05-01)

High Detection Rates for Prostate-specific Membrane Antigen–avid Prostate Cancer Recurrence at Low Prostate-specific Antigen levels on Extended Axial Field-of-view Positron Emission Tomography/Computed Tomography
by: Sarah Thomas, et al.
Published: (2025-01-01)

Clinicopathological Significances of Positive Surgical Resection Margin after Radical Prostatectomy for Prostatic Cancers: A Meta-Analysis
by: Minseok Kim, et al.
Published: (2022-09-01)

Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer
by: Zhaojun Yu, et al.
Published: (2023-04-01)

Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
by: Takuya Aizawa, et al.
Published: (2023-10-01)

Lung malignancy in prostate cancer: A report of both metastatic and primary lung lesions
by: Lael Reinstatler, et al.
Published: (2018-01-01)

A case report of a prostate cancer metastasis in the pancreas exhibiting vascular encasement
by: Lauren Phung, BS, et al.
Published: (2024-03-01)

Is PSA Still the Best Predictor for Biochemical Recurrence after Radical Prostatectomy in High-Risk Prostate Cancer?
by: Serkan Akan, et al.
Published: (2022-10-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer
by: Daojun Lv, et al.
Published: (2021-05-01)

Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study
by: Antonio Benito Porcaro, et al.
Published: (2015-10-01)

Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy
by: Blaz Pavlovic, et al.
Published: (2024-08-01)